|
451 |
Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia
Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 1, date:1.2011: 41-50
|
|
|
|
452 |
Pharmacokinetics of Diazepam Administered Intramuscularly by Autoinjector versus Rectal Gel in Healthy Subjects
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 8, date:8.2011: 585-597
|
|
|
|
453 |
Pharmacokinetics of Metformin in Girls Aged 9 Years
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 11, date:11.2011: 735-738
|
|
|
|
454 |
Pharmacokinetics of Oxybutynin Chloride Topical Gel
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 8, date:8.2011: 559-571
|
|
|
|
455 |
Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 6, date:6.2011: 405-414
|
|
|
|
456 |
Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment
Enthalten in Clinical pharmacokinetics Bd. 49, 18.12.2012, Nr. 9, date:9.2010: 607-618
|
|
|
|
457 |
Pharmacokinetics, Safety and Tolerability of Bencycloquidium Bromide, a Novel Selective Muscarinic M1/M3 Receptor Antagonist, After Single and Multiple Intranasal Doses in Healthy Chinese Subjects
Enthalten in Drugs in R & D Bd. 12, 27.11.2012, Nr. 1, date:3.2012: 17-28
|
|
|
|
458 |
Pharmacological Rhythm and Rate Control Treatment for Atrial Fibrillation
Enthalten in The Patient Bd. 3, 24.8.2012, Nr. 1, date:3.2010: 33-43
|
|
|
|
459 |
Pharmacology of Morphine in Obese Patients
Enthalten in Clinical pharmacokinetics Bd. 48, 13.9.2012, Nr. 10, date:10.2009: 635-651
|
|
|
|
460 |
Pharmacotherapy for Breakthrough Cancer Pain
Enthalten in Drugs Bd. 72, 12.12.2012, Nr. 2, date:1.2012: 181-190
|
|
Administration
